The Obesity Paradox: Love handles and Longevity

The Obesity Paradox: Love handles and Longevity

We’ve all heard it a million times: eat well, exercise, lose weight—because thin is good and fat, any fat, is... well, bad

Just take a look at those BMI tables. They tell us that a ‘normal’ weight is having a BMI between 18.5 and 25, overweight is having a BMI between 25 and 30 and anything above that is in the obese category. So, the goal for us all then is a BMI of 25 and below, right?

But then we are presented with the ‘obesity paradox’

What’s that, I hear you ask? Oh, just the idea that carrying a little extra padding might actually prolong your life in certain situations.? Yes, those love handles might be your life raft in a storm

How Is This Possible?

It turns out, having a BMI in the "overweight" range (25–29.9) isn’t all doom and gloom. In fact, research shows that people with a little extra cushion tend to live about the same or even a little longer than the rest of us


Whether it’s a bout of pneumonia, a cardiac event, or some other stressful medical situation, that extra weight seems to give you an edge. Your fat is like the ultimate backup generator—it kicks in when the power goes out, especially in older individuals

Fat's Secret Weapon?

Scientists have a few theories for why this happens:?

Energy Reserves: Extra fat stores act as a reserve fuel tank during illness, when your body needs more energy to heal

Anti-Inflammatory Effects: Adipose tissue (that’s the fancy word for fat) releases certain hormones that might actually help regulate inflammation in moderate amounts

Proactive Healthcare: Overweight individuals are often flagged as “at risk” by doctors, leading to more frequent checkups and earlier interventions. Sometimes, paranoia pays off

The Sweet Spot

Before you start cancelling your gym membership, let’s be clear: the obesity paradox applies mostly to mildly overweight individuals—not those tipping into the "severely obese" category. Carrying a extra few pounds might save your life, but carrying a whole spare tyre could still lead to problems like diabetes, heart disease, and mobility issues

Think of it as a bell curve: too little fat and your body’s unprepared; too much and it’s overwhelmed

So, what’s the sweet spot? It seems having a BMI between 25–29.9, where your fat is juuuuust right

Now we have access to effective treatments for obesity in the form of GLP-1s and people are being treated widely it would seem sensible to treat patients with BMI’s that are above thirty and probably presenting with at least one co-morbidity.

How are we doing?

Let’s turn our attention to the typical patient profile and let’s use the world’s biggest market as a worked example, the US. The typical patient profiles are outlined below:

Non-Private ~30% of the patient population in the US

  • Average age: 46.2 years
  • Average BMI: 38.5
  • Gender: 66% female
  • Co-morbidities: 50–60% of patients prescribed GLP-1s for obesity also have diabetes. Other co-morbidities also include hypertension, dyslipidaemia, and non-alcoholic fatty liver disease are common

Private/private insurance ~ 70% of the patient population in the US

  • Average age: 49 ?years
  • Average BMI: 31.5
  • Gender: 75% female
  • Co-morbidities: Fewer co-morbidities

What do these trends reveal?

Non-private patients: Treatments start at more advanced stages of obesity with significant co-morbidities

Private patients: Treatments appear to be geared more towards weight management

Gender gap: Women are more likely than men to seek access to obesity treatments

What are the Implications?

This snapshot underscores the disparities in obesity treatment by insurance type, emphasising the need for more equitable access. It also highlights the dual role of GLP-1s in managing obesity and co-morbid metabolic conditions

The Takeaway

So, what’s the moral of the story? Should you embrace your dad bod as a badge of longevity? Not quite. The obesity paradox isn’t an excuse to skip the gym and dive headfirst into a pizza buffet. It’s more a reminder that health is complicated, and BMI is just one piece of the puzzle

Still, if anyone side-eyes you for that extra helping of pudding after the Sunday roast, just smile and say, “it’s my biological insurance policy”

andy jones

Creative Director, Copywriter, Healthcare Specialist, Author

3 个月

Nice read, Carsten - it sure is a complex issue

Marcus Metcalfe

Co-founder Placing Interim & Advisory Consultants with US & European BioPharma clients providing immediate & flexible talent??Senior Executive Search (Perm)??Deep network & expertise in Market Access & HEOR

3 个月

what i like about this Carsten Edwards is it's story telling, it's relatable and not just facts

Svetlana Kalabina

Market Access | Pricing | Reimbursement

3 个月

Great article Carsten - continious education and transaprency around this topic is important

Dr Max Noble

CEO at VISFO

3 个月

Nicely written, as always, such a complex psychosocial pandoras box of education, fast food, UPFs, bogofs, advertising, misinformation and they are the positives. Glucose is not our friend, insulin does its best to manage it but gets overloaded, GLP1s are one part of the solution but not a panacea. Surely fixing the inputs will improve the outcomes. Saturday musings..

要查看或添加评论,请登录

Carsten Edwards的更多文章

  • Save Money, Skip the Gym: Eat Better and Lose Weight

    Save Money, Skip the Gym: Eat Better and Lose Weight

    Just as you cannot save your way to prosperity, it seems that you can't exercise yourself thin. According to this…

    9 条评论
  • How to become a Lion and the Price of Roaring

    How to become a Lion and the Price of Roaring

    A Question of Exhaustion As Christmas draws near and families from all corners of the globe prepare to converge in a…

    1 条评论
  • The Brits Are Coming… Or Are They?

    The Brits Are Coming… Or Are They?

    It's Christmas time and the parties are coming thick and fast. At this time of the year it gets to be fun and…

    27 条评论
  • "Death by a Thousand Cuts"

    "Death by a Thousand Cuts"

    Lingchi, or "death by a thousand cuts," was a historical form of execution practiced in parts of Southeast Asia. This…

  • ISPOR – Sunshine, Sangria and Systematic Reviews

    ISPOR – Sunshine, Sangria and Systematic Reviews

    This week, the leading minds of the pharmaceutical world gather to delve into the intricacies of health economics and…

    2 条评论
  • Look at my Shoes

    Look at my Shoes

    Once, while washing my hands in the men's loo at work (that's British for toilet or restroom if you are from the…

    1 条评论
  • GLP-1 Drugs: Between Hype, Hope, and a little Dose of Caution

    GLP-1 Drugs: Between Hype, Hope, and a little Dose of Caution

    In 1987, Dr Joel Habener and his team at Harvard Medical School identified GLP-1, a hormone produced in the gut that…

  • Espresso Machines and Microwave Cookers: In Defence of the Specialist

    Espresso Machines and Microwave Cookers: In Defence of the Specialist

    I always enjoy this debate, especially when it’s applied to pharmaceuticals and biotech. In our business should we…

  • PICO Ahoy!

    PICO Ahoy!

    Both agencies and pharmaceutical companies appear to be raising the alarm to general quarters, largely due to the…

    1 条评论
  • The Costs of Slimming Down

    The Costs of Slimming Down

    Given the impressive data on GLP-1 medications—highlighting both significant weight loss and meaningful clinical…

    2 条评论

社区洞察

其他会员也浏览了